We have reported previously that striatal projection neurons are differentially affected in the course of Huntington's disease, and in a prior patient report we noted that differential loss of striatal projection neurons occurs also in patients with presymptomatic Huntington's disease. Striatal neurons projecting to the external segment of the globus pallidus or the substantia nigra show evident loss, whereas those projecting to the internal segment of the globus pallidus appear relatively spared at presymptomatic and early stages of symptomatic Huntington's disease. We now report similar findings in a second apparently presymptomatic Huntington's disease allele carrier. 
The histopathological hallmark of Huntington's disease (HD) is pronounced atrophy of the striatum, especially the caudate nucleus. Within the striatum, there is differential involvement of subpopulations of striatal neurons. Striatal interneurons cocontaining the peptides somatostatin and neuropeptide Y and the enzyme NADPH-diaphorase appear to be spared in patients with HD 11, 2) . Similarly, the perikarya of striatal cholinergic interneurons appear also to be spared [ 3 , 41, though there is an impressive loss of striatal choline acetyltransferase activity and of cholinesterase staining within the striatum [ 5 , 61. These classes of striatal interneurons comprise only a small fraction of all striatal neurons. The overwhelming majority of striatal neurons are projection neurons, and striatal projection neurons are markedly depleted in the course of HD.
Striatal projection neurons are subdivided into separate populations based on their projection targets and neuropeptide content 17-13f . Striatal neurons projecting to the external segment of the globus pallidus (GPe) are enriched in enkephalins (ENK), whereas striatal neurons projecting to the internal segment of the globus pallidus (GPi) or to the substantia nigra (SN) are enriched in substance P (SP) 112, 13 [16) . We now report preferential loss of striato-external pallidal projection neurons in a second presymptomatic carrier of the HD allele.
Case Report and Methods

Case Report
The subject was a man from a family with several individuals afflicted with typical Huntington's disease. His birth, development, adolescence, and early adulthood were apparently normal. An excellent athlete, he was offered and declined a college baseball scholarship. After graduation from high school, he served in the military for 4 years and was honorably discharged. He subsequently went into the roofing business with one of his reiatives. Two to 3 years before his death, family and friends noticed changes in his personality. Formerly a pleasant and agreeable individual, he became unpredictably temperamental and argumentative, and sometimes physically violent. H e began to use over-the-counter stimulants frequently but did not abuse illicit drugs. H e continued to work as a roofer until the time of death and his ability to work was unimpaired. Specifically, there was no clumsiness. incoordination, or decrease in his rate of work. No adventitious movements were noted by friends or family members. His father did notice that he had become somewhat fidgety and had difficulty sitting still. N o relative, including those involved in the care of family members suffering from HD, noticed any movements that resembled chorea. At the age of 28 years, in the course of an argument, he was killed by a gunshot to the trunk.
After appropriate clearances, an autopsy was performed approximately 20 hours after death. The brain was removed in the routine fashion and hemisected in the midsagittal plane. One-half was fixed in 10%' neutral buffered formalin and the other one-half frozen to -80°C immediately after removal. After 14 days of fixation, the formalin-fixed half was cut up into I-cm-thick coronal sections and selected tissue blocks were prepared for routine light microscopic study. Blocks through the pallidum and nigra were used for immunohistochemical analysis after 6 additional months in fixative.
Neuropathological analysis was performed by one of the authors (W.O.W.) several months before assessment of HD allele status. In a thorough survey of the cerebral cortex, subcortical white matter, basal ganglia, thalamus, midbrain, pons, medulla, and cerebellum, there were no significant neuropathological abnormalities. Specifically, there was no evidence of caudate or cerebral cortical atrophy, no obvious loss of striatal neurons, and no striatal or cortical gliosis. Masson trichrome-stained sections confirmed the absence of striatal gliosis.
Method
LINKAGE ANALYSIS. Most members of this pedigree were examined for evidence of HD by two of the authors (R.L.A. and L.S.D.) and blood samples were drawn for use in linkage analysis. D N A was extracted from the blood samples of members and from a frozen block of cerebellar cortex of the subject using standard techniques. The entire family study, including extraction of D N A from brain and blood samples, was performed in duplicate by two independent technicians. Southern blots were generated using appropriate restriction enzymes for the following informative polymorphic D N A markers that are known t o be closely linked to the HD gene: pK082/HidIlI, Y N Z~~I P J -~.
and BS674IAciI. The resulting genotypes at these markers for each relevant member of the Family were coded into the MLINK function of the LINKAGE progrnm { 171. N o recombination events were observed among the nine informative meiodc events scored.
All markers were conservatively placed at 2(% recombination distance from the H D locus; these values for theta were combined with ages of onset and liability classes for each family member to calculate an assessment of accuracy for gene-carrier status of the subject.
IXtML"OH1SI'OCHEMISI'KY.
The integrity of specific types of striatal projection neurons was examined by immunohistochemical staining of their terminals for ENK and SP in coronal sections of the pallidum and substantia nigra. Well-ch;tracterizeci antisera directed against Leu-enkephalin (dilution, 1 : 500; INCstar, Stillwater. MN), met-enkephalinArg6-Gly--LeuX (dilution, 1 :500; gift of Dr G. J . Dockray), and SP (dilution, 1 : 1,000; Accurate Chemical and Scientific-, Westbury, NY) were used, and immunohistochemistry was performed using the peroxidase-antiperoxidase technique as previously described [ 141. Striatal gliosis was assessed with glial fibrillary acidic protein (GFAP) immunoreactivity using a well-characterized antiserum (INCstar; 1/500).
The extent of the reduction of immunohistoc-hem.ically stained fibers in G P and SN was determined with quantitative image analysis, using a Newvicon camera, video capture board, MacIIci computer, and software called Image (developed by Wayne Razband, National Institutes of Hedth. Bethesda, MD). Thresholding techniques { 181 were used to measure fiber abundance in the presymptomatic brain compared with control subjects. Nine fields of the GPe, 18 jields of the GPi, and five fields of the nigra of a single section of the presymptomatic subject and control sections matched for level of the neuraxis were viewed with a 40 x objective. and the gray scale adjusted to maximize contrast between labeled fibers and unstained background. Gray scale thresholds 'were set to "extract" labeled fibers by removing pixels with gray scale values between the thresholds from the image. The area of the removed pixels was computed and fiber abundance expressed as the area of extracted pixels divided by the total area of the field. ENK-immunoreactive (IR) fiber abundance in the GPe and SP-IR fiber abundance in GPi and nigra were compared with fiber abundance determinations in four control subjects matched for time in fixative. Time in fixa.tive is a crucial variable affecting the intensity of staining of striatal efferent fibers (A. Reiner and colleagues, unpublished data). Threshold analysis of GPe ENK-IR fiber abundance and SP-IR fiber abundance in the GPi and nigra was also performed on the previously reported presymptomatic specimen and three additional control subjects.
Results
Linkuge Analysis
Results of the linkage analysis revealed a 97% probability that the subject was a carrier of the HD d e l e .
Imrnunobistocbemist~
GFAP staining of the striaturn revealed no increase in GFAP imrnunoreactivity cornpared with control striaturn.
In normal pallidum, dendrites of pallidal neurons axe coated with the intensely irnrnunoreactive terminals of striatopallidal neurons, giving the pallidal dendrites the so-called woolly fiber appearance (191 (Figs 1 , 2) . In the pallidurn of the presyrnptornatic individual, SP-I R woolly fibers in the GPi were normal in appearance, but there was a reduction in the number of terminals of ENK-IR fibers in the GPe (see Figs 1, 2) . and of SP-IR fiber abundance in control GPi was 1.9%.
nals. Shrinkage effects are of especial importance in analyzing nigral SP-IR fibers. In our prior studies of patients with H D and presymptomatic HD, changes in nigral SP-IR fiber density were accompanied by reduction of the area of the nigra containing SP-IR fibers. In this presymptomatic specimen, there were only subtle changes in either nigral SP-IR area or nigral SP-IR fiber density, suggesting that in this individual, striatonigral projection neurons are less affected than striato-GPe projection neurons. It is possible that the degeneration of striato-GPe neurons begins before the degeneration of striatonigral neurons. Although our immunohistochemical results most likely reflect the degeneration of striatal projection neurons, we cannot exclude the possibility that the perikarya of striato-GPe and striatonigral projection neurons are intact but have lost the ability to synthesize these neuropeptides.
Discussion
The immunohistochemical findings in this presymp- We are very grateful to the family of this subject for their cooperation and support. We also thank Dr Charles Harlan, Davidson County (TN) Medical Examiner for his cooperation in the performance of the autopsy. We thank Ellen Karle and Betry Cook for their excellent technical assistance. met criteria for a diagnosis of HD, the significance of the findings in this case would be undiminished. The absence of striatal cell loss and gliosis on routine neuropathological examination indicates that the subject 210:561-564
